Hummingbird Diagnostics GmbH
PrivateLast Round
Grant
Apr 29, 2020
Total Funding Raised
$708,382
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Hummingbird Diagnostics GmbH is a biotechnology company that develops small RNA-based blood tests for the early detection and characterization of diseases, with an initial focus on lung cancer and Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical AI, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hummingbird Diagnostics GmbH Comparables
Compare Hummingbird Diagnostics GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exai Bio | 80% | |
| Flomics Biotech | 79% | |
| Aptorum Group Limited | 78% |
Hummingbird Diagnostics GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 29, 2020 | ||||
| Seed | Jan 1, 2016 |
Key People
Founding team and executive leadership
Hummingbird Diagnostics GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreyBird Ventures | VC Round, Seed |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 40% MoM, reaching 450.
- Feb 4, 2026
Monthly visitors increased 347% MoM.
Hummingbird Diagnostics GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hummingbird Diagnostics GmbH's valuation, stock price, and market status.
Is Hummingbird Diagnostics GmbH a public or private company?
Hummingbird Diagnostics GmbH is a private company.
What is the current stock price of Hummingbird Diagnostics GmbH?
Hummingbird Diagnostics GmbH is a private company with no public stock price. No recent secondary market data is available.
How much is Hummingbird Diagnostics GmbH worth (valuation)?
Valuation information for Hummingbird Diagnostics GmbH is not publicly available.
Can I buy Hummingbird Diagnostics GmbH stock?
Hummingbird Diagnostics GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hummingbird Diagnostics GmbH's last funding round?
Funding round information for Hummingbird Diagnostics GmbH is not publicly available.
Who are the main investors in Hummingbird Diagnostics GmbH?
Investor information for Hummingbird Diagnostics GmbH is not publicly disclosed.
Will Hummingbird Diagnostics GmbH IPO soon?
No public IPO plans have been announced for Hummingbird Diagnostics GmbH.
How can I track Hummingbird Diagnostics GmbH secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hummingbird Diagnostics GmbH's secondary market activity and sign up for updates.